S. Korea's biopharmaceutical exports hit record US$6.6 bln in Jan.-Sept. period

This will let Google show Yonhap news articles that match or are related to your search

SEOUL, Oct. 8 (Yonhap) -- South Korea's exports of biopharmaceutical products reached a record US$6.6 billion in the first nine months of this year, led by robust demand in Europe, government data showed Thursday.

Exports of biopharmaceutical products rose 15.8 percent from a year earlier to an estimated $6.6 billion in the January-September period, according to the Ministry of Food and Drug Safety.

The shipments accounted for approximately 73 percent of the country's total pharmaceutical exports of $9 billion during the period, the latest findings showed.

In the third quarter alone, biopharmaceutical exports climbed 15.6 percent on-year to $2.07 billion.

The United States was the largest export destination during the nine months, with shipments totaling $1.07 billion, or 16.3 percent of all shipments sent abroad.

Switzerland followed with $1.01 billion, while Hungary came in third place at $920 million.

Exports to Europe showed particularly strong growth, with seven of South Korea's top 10 export destinations located in the region, supported in part by robust demand for contract development and manufacturing organization (CDMO) services and biosimilar products.

The Ministry of Food and Drug Safety's building is seen in this photo provided by the ministry. (PHOTO NOT FOR SALE) (Yonhap)

ejkim@yna.co.kr (END)

S. Korea's biopharmaceutical exports on pace to hit new record in H1

S. Korea's drug exports top $10 bln for 1st time in 2025: data

Sales of major S. Korean bio firms up 16 pct in Q1: report

S. Korea's biopharmaceutical exports hit record US$6.6 bln in Jan.-Sept. period

这将使谷歌能够向您展示与您的搜索匹配或相关的韩联社新闻文章。

首尔，10月8日（韩联社）——韩国政府周四公布的数据显示，受欧洲强劲需求的推动，今年前九个月韩国生物制药产品出口额达到创纪录的66亿美元。

据食品药品安全部统计，今年1月至9月，生物制药产品出口额同比增长15.8%，达到约66亿美元。

最新调查结果显示，这些货物的出口额约占该国同期90亿美元药品出口总额的73%。

仅第三季度，生物制药出口额就同比增长 15.6%，达到 20.7 亿美元。

在过去的九个月里，美国是最大的出口目的地，出口总额达 10.7 亿美元，占所有出口货物的 16.3%。

瑞士以 10.1 亿美元位居第二，匈牙利以 9.2 亿美元位列第三。

对欧洲的出口增长尤为强劲，韩国十大出口目的地中有七个位于该地区，这在一定程度上得益于对合同开发和生产组织 (CDMO) 服务和生物类似药的强劲需求。

这张照片由韩国食品药品安全部提供，照片中是该部办公楼。（照片禁止出售）（韩联社）

ejkim@yna.co.kr (完)

韩国生物制药出口有望在上半年创下新纪录

数据显示，韩国药品出口额有望在2025年首次突破100亿美元大关。

报告显示，韩国主要生物技术公司第一季度销售额增长16%。

韩国生物制药出口额在1月至9月期间创下66亿美元的纪录。